 |
SYDNEY, Aug. 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of...
Social media campaigns, digital ads, and influencer partnerships dominate today’s marketing industry. However, promotional products are making a comeback as brands look for unique and creative ways ...
Daily Bulletin
On some level, content marketing is used in every digital marketing campaign. Important messaging about a product, service, or brand will be conveyed through content marketing assets, whether writte...
Daily Bulletin
Corporate evolution has accelerated dramatically in today's volatile business environment, requiring leaders to develop sophisticated approaches to managing workforce transitions across technologica...
Daily Bulletin
